Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FY8HZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,359
Award facts
- Contract value 100% obligated
- $39,359.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $39,359.40 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination maintenance inhaler containing fluticasone propionate, umeclidinium, and vilanterol used in the treatment of chronic obstructive pulmonary disease. The contract, executed on December 1, 2025, with a completion date of December 2, 2025, was awarded competitively without set-aside restrictions under firm fixed pricing terms. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare systems globally. The parent IDC enables AmerisourceBergen to supply a diverse range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains extensive capabilities to fulfill both routine and specialized medical procurement requirements through open competition across the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FY8HZ?
SPE2DR26FY8HZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FY8HZ worth?
The government has obligated $39,359 on SPE2DR26FY8HZ.
Is contract SPE2DR26FY8HZ an order under another contract?
Yes. SPE2DR26FY8HZ is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8HZ competed?
The extent of competition for SPE2DR26FY8HZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award